Format

Send to

Choose Destination
See comment in PubMed Commons below
Med Klin (Munich). 1997 Dec;92 Suppl 5:44-9. doi: 10.1007/BF03041980.

[Long-acting beta(2)-adrenoceptor agonists for asthma and COPD].

[Article in German]

Author information

1
Krankenhaus Grosshansdorf, Zentrum für Pneumologie und Thoraxchirurgie, LVA Hamburg, Grosshansdorf. 100260.1723@COMPUSERVE.COM

Abstract

The introduction of long-acting beta(2)-adrenoceptor agonists such as salmeterol and formoterol has opened new perspectives for the treatment of asthma and, possibly, also COPD. These drugs are particularly useful in bronchial asthma and meet the requirements of several treatment guidelines to combine long-acting bronchodilator therapy with inhaled corticosteroids in patients with persistent asthma. The role of long-acting beta(2)-adrenoceptor agonists for management of COPD is less clear. While effects on lung function will be small, parameters of improved quality of life and exercise tolerance may verify the clinical role of long-acting beta(2)-adrenoceptor agonists for COPD treatment in the future.

PMID:
19479397
DOI:
10.1007/BF03041980
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center